Maraba Virus as a Potent Oncolytic Vaccine Vector-Reference-Cited by-同舟云学术

Maraba Virus as a Potent Oncolytic Vaccine Vector

Published:2014-02 Issue:2 Volume:22 Page:420-429
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Pol Jonathan G,Zhang Liang,Bridle Byram W,Stephenson Kyle B,Rességuier Julien,Hanson Stephen,Chen Lan,Kazdhan Natasha,Bramson Jonathan L,Stojdl David F,Wan Yonghong,Lichty Brian D

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Oncolytic virotherapy;Russell;Nat Biotechnol,2012

2. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer;Heo;Nat Med,2013

3. Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies;Karapanagiotou;Clin Cancer Res,2012

4. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck;Harrington;Clin Cancer Res,2010

5. Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis;Miest;Mol Ther,2011

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms;Journal of General Virology;2024-08-22

2. Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling;Journal for ImmunoTherapy of Cancer;2024-07

3. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

4. Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T cell receptor signalling;2024-04-03

5. A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?;Viruses;2024-02-01